Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy

David Patrick Kateete, Monica M Mbabazi, Faith Nakazzi, Fred A Katabazi, Edgar Kigozi, Willy Ssengooba, Lydia Nakiyingi, Sharon Namiiro, Alphonse Okwera, Moses L Joloba, Adrian Muwonge

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Information on microbiota dynamics in pulmonary tuberculosis (TB) in Africa is scarce. Here, we sequenced sputa from 120 treatment-naïve TB patients in Uganda, and investigated changes in microbiota of 30 patients with treatment-response follow-up samples. Overall, HIV-status and anti-TB treatment were associated with microbial structural and abundance changes. The predominant phyla were Bacteroidetes, Firmicutes, Proteobacteria, Fusobacteria and Actinobacteria, accounting for nearly 95% of the sputum microbiota composition; the predominant genera across time were Prevotella, Streptococcus, Veillonella, Haemophilus, Neisseria, Alloprevotella, Porphyromonas, Fusobacterium, Gemella, and Rothia. Treatment-response follow-up at month 2 was characterized by a reduction in abundance of Mycobacterium and Fretibacterium, and an increase in Ruminococcus and Peptococcus; month 5 was characterized by a reduction in Tannerella and Fusobacterium, and an increase in members of the family Neisseriaceae. The microbiota core comprised of 44 genera that were stable during treatment. Hierarchical clustering of this core's abundance distinctly separated baseline (month 0) samples from treatment follow-up samples (months 2/5). We also observed a reduction in microbial diversity with 9.1% (CI 6-14%) of the structural variation attributed to HIV-status and anti-TB treatment. Our findings show discernible microbiota signals associated with treatment with potential to inform anti-TB treatment response monitoring.

Original languageEnglish
Article number24486
JournalScientific Reports
Issue number1
Publication statusPublished - 29 Dec 2021


Dive into the research topics of 'Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy'. Together they form a unique fingerprint.

Cite this